VI Malaga Conference on Alzheimer’s

Presentation

The Conference aims to establish a space for update and discussion dedicated to the knowledge of Alzheimer’s disease and other dementias.

So it brings together prestigious professionals of different scientific fields in order to exchange information and ideas about theory, research and practice in the field of dementia.

Con este afán, continuando el camino ya andado con la anterior edición de la Conferencia, el programa científico, diseñado con un carácter multidisciplinar, se ha estructurado en torno a talleres prácticos, mesas redondas moderadas por expertos y conferencias magistrales.

Como novedad importante, en esta sexta edición la Conferencia acogerá la celebración, el día 16 de mayo, del III Simposio sobre Genética de la Demencia, organizado por CIBERNED, el consorcio DEGESCO e IANEC.

ORGANIZATION

III Symposium on Dementia Genetics

CIBERNED – Dementia Genetics Spanish Consortium (DEGESCO)
Malaga, May 16, 2019

Organizers

Official program

08:30 – 09:00 ACCREDITATION

09:00 – 09:15 WELCOME
José María García-Alberca, Andalusian Institute for Neuroscience (IANEC),
Jordi Clarimón Hospital de la Santa Creu i Sant Pau, Barcelona.

09:15 – 10:25 PRESENTATION OF NEW GROUPS
Chairs: Agustín Ruiz, Fundació ACE. Barcelona, CIBERNED, Pascual Sánchez-Juan, Marqués de Valdecilla University Hospital, Santander.

09:15 – 09:25 Carmen Antúnez Group, University Clinical Hospital Virgen de la Arrixaca, Murcia

09:25 – 09:35 José María García-Alberca & José Luis Royo Group, Andalusian Institute for Neuroscience (IANEC), University of Malaga.

09:35 – 09:45 Guillermo Amer Group University Hospital Son Espases, Palma de Mallorca.

09:45 – 09:55 Diego Real de Asúa Group, Hospital la Princesa, Madrid.

09:55 – 10:05 Guillermo García-Ribas Group, University Hospital Ramón y Cajal, Madrid.

10:05 – 10:15 Pablo Mir Group, Biomedicine Institute of Seville.

10:15 – 10:25 Gerard Piñol Group, Santa María Hospital, Lleida.

10:25 – 11:00 Coffee-Break

11:00 – 11:45 KEYNOTE SPEECH
Chair: Jordi Clarimón, Hospital de la Santa Creu i Sant Pau, Barcelona.

Machine learning for the study of neurodegeneration.
Juan A. Botía, Department of Information and Communications Engineering, University of Murcia, Spain; Hon. Senior Research Fellow, Institute of Neurology, University College London, UK.

11:45 – 12:15 ONGOING PROJECTS

Update Projects GR@ACE / EADB.
Agustín Ruiz, Fundació ACE, Barcelona; CIBERNED.
Jordi Clarimón, Hospital de la Santa Creu i Sant Pau, Barcelona; CIBERNED.

FIS-DEGESCO: Characterization of loci regulating protein levels (pQTLs) associated with Alzheimer’s disease in cerebrospinal fluid. Role of pQTLs and their associated genetic networks in the progression to dementia of subjects with mild cognitive impairment.
Pascual Sánchez-Juan, Marqués de Valdecilla Hospital, Santander; CIBERNED.

12:15 – 13:00 PROPOSALS FOR NEW PROJECTS
Chair: Miguel Medina, CIBERNED.

Effect of intermediate alleles on neurodegenerative diseases.
Victoria Álvarez, Central University Hospital of Asturias.

Number of copies in SIRPB1 and their involvement in Alzheimer’s disease.
José Luis Royo, University of Málaga.
José María García-Alberca, Andalusian Institute of Neuroscience (IANEC), Málaga.

Consortium for Dementia with Lewy Bodies and FenoGWAs in Dementia with Lewy Bodies.
Pau Pastor, University Hospital Mútua de Terrassa.

13:00 – 13:30 DISCUSSION / OPEN DEBATE

Official program

15 May 2019

16:00 – 20:30 COMPREHENSIVE APPROACH TO BEHAVIORAL DISORDERS IN DEMENTIA
Dr. José María García-Alberca, Psychiatrist. Clinical Psychologist. Alzheimer Treatment and Research Center, Andalusian Institute for Neuroscience (IANEC), Malaga.

Program

  • Concept, classification and diagnosis in the clinical practice of BPSD.
  • Evaluation instruments.
  • Pharmacological treatment: use, choice, dose, adverse effects, interactions.
  • Non-pharmacological therapies.
  • MPractical handling.

Cada uno de lo inscritos en el Curso will receive a free copy of the book: Alzheimer’s Disease. Non-pharmacological therapies for psychological and behavioral symptoms, written by Dr. José María García-Alberca.

Official program

Thursday, 16

15:30 – 16:00 Registration

16:00 – 17:45 WORKSHOP 1
Update on aphasia. New approaches for treatment.
Marcelo Berthier, Centro de Investigaciones Médico-Sanitarias (CIMES), University of Málaga.

17:45 – 18:15 Coffee-Break

18:15 – 20:00 WORKSHOP 2
The importance of neuropsychology: beyond screening tests
Tamara Marín, Andalusian Institute for Neuroscience (IANEC), Malaga.

Friday, 17

08:45 – 10:00 SESSION: CHALLENGES AND PROGRESS IN EARLY DIAGNOSIS OF ALZHEIMER’S DISEASE

Chair: José Luis Royo, University of Málaga.

Use of genetics for the discovery of biomarkers and for revealing the genetic architecture of neurodegenerative disorders
Jordi Clarimón, Hospital de la Santa Creu i Sant Pau, Barcelona; CIBERNED.

GWAS in the Spanish population: the GRA@ACE/DEGESCO project.
Agustín Ruiz,Fundació ACE, Barcelona; CIBERNED.

Neuropsychological biomarkers for the detection of cognitive changes in preclinical Alzheimer’s disease.
Cristóbal Carnero Pardo, Hospital Universitario Virgen de las Nieves, Fidyan Neurocenter, Granada.

10:00 – 10:45 HOT TOPIC LECTURE

MOPEAD, Models of Patient Engagement for Alzheimer’s Disease.
Mercè Boada, Fundació ACE, Barcelona, CIBERNED.

Chair: José María García-Alberca, Andalusian Institute for Neuroscience (IANEC), Malaga.

10:45 – 11:15 Coffee-Break

11:15 – 12:30 SESSION: PATHOGENESIS OF ALZHEIMER’S DISEASE. WHAT HAVE WE LEARNED RECENTLY?

Chair: Natalia García-Casares, Universidad de Málaga.

Deciphering the implication of reactive astrocytes in Alzheimer’s disease: new pathogenic approach of therapeutic interest.
Antonia Gutiérrez Pérez, Institute of Biomedical Research of Málaga (IBIMA), University of Málaga.

Towards a transcriptomic definition of the microglial response in Alzheimer’s disease: differences between animal models and patients.
Javier Vitorica Ferrández. Seville Biomedical Institute (IBIS), University of Seville.

The impact of tau pathology on Alzheimer’s disease. Opportunities for a therapeutic intervention.
Miguel Medina, CIBERNED, Reina Sofia Foundation, CIEN Foundation.

12:30 – 13:00 OFFICIAL OPENING

13:00 – 14:15 SESSION: INNOVATIVE STRATEGIES IN TREATMENT (I)
Chair: Fermín Mayoral, Malaga Biomedical Research Institute (IBIMA).

Modulation of the cannabinoid system: a new perspective for the treatment of Alzheimer’s disease.
Ángeles Martín Requero, Centro de Investigaciones Biológicas (CSIC), CIBERER, Madrid.

Nanoliposomes as a therapeutic tool for Alzheimer´s disease.
Francisco Wandosell, Severo Ochoa Molecular Biology Centre (CSIC), CIBERNED, Madrid.

Relationship between Hearing Loss and Cognitive Impairment: The Brain Listens.
 Elena Vila, Quiron Salud Hospital, Malaga.

16:00 – 16:45 HOT TOPIC LECTURE
The challenge of preventing dementia.
José Luis Molinuevo, Alzheimer’s Disease and Other Cognitive Disorders Unit, IDIBAPS, Hospital Clinic, Barcelona. Barcelona Beta Brain Research Center, Fundació Pasqual Maragall, Barcelona.

Chair: Tamara Marín, Andalusian Institute for Neuroscience (IANEC), Málaga.

16:45 – 18:00 SESSION: EMERGING CONCEPTS

Chair: Miguel Ángel Barbancho, University of Málaga.

Alterations of intestinal microbiota in Alzheimer’s disease. Clinical Evidence and Pathways to Follow.
Esteban Orenes, University of Murcia.

Altered Patterns and Sleep Loss as Risk Factors for Cognitive Impairment and Alzheimer’s Disease.
José Luis Cantero, Laboratory of Functional Neuroscience, Pablo de Olavide University, Seville.

Inflammatory reactivity in major surgery and cognitive impairment.
Pascual Sánchez-Juan, Marqués de Valdecilla University Hospital, Santander.

18:00 – 18:30 Coffee-Break

18:30 – 19:45 SESSION: GOOD TREATMENT AND DIGNITY IN THE CARE OF PEOPLE WITH DEMENTIA

Chair: Ángela García Cañete, Andalusian Confederation of Federations of Relatives of People with Alzheimer’s Disease and Other Dementias (ConFEAFA).

Needs and quality of life of people with dementia and their family carers.
Manuel Gonçalves Pereira, Universidade Nova de Lisboa, Portugal.

Pain and Unspoken Symptoms: The Other Dementia.
José Manuel Marín Carmona, Municipal Memory Program and Dementia, Malaga City Council.

Palliative care and quality care for people with advanced dementia.
José Antonio López Trigo, President of the Spanish Society of Geriatrics and Gerontology.

Saturday, 18

08:45 – 10:00 SSESSION: TECHNOLOGICAL AND SOCIO-SANITARY INNOVATIONS IN ALZHEIMER’S DISEASE AND OTHER DEMENTIAS.

Chair: Saray Hevilla, Andalusian Institute for Neuroscience (IANEC), Malaga.

SIIA Project: Comprehensive Outpatient Intervention Program.
Carolina López de Luis, Center of State Reference for Attention to People with Alzheimer’s Disease and other Dementias, Salamanca.

Design of spaces for people with Alzheimer’s disease.
Pablo Lara, Centre for Medical-Sanitary Research (CIMES), University of Malaga.

Non-pharmacological therapies. New approaches.
Manel Sánchez Pérez, Sagrat Cor Hospital, Martorell, Barcelona.

10:00 – 10:45 HOT TOPIC LECTURE

New perspectives on risk factors and pathogenic mechanisms in Alzheimer’s syndrome.
Ángel Cedazo, Center for Alzheimer Research, Karolinska Institutet, Stockholm, Sweden.

Chair: Esther Gris, Andalusian Institute for Neuroscience (IANEC), Malaga.

10:45 – 11:15 Coffee-Break

11:15 – 12:00 HOT TOPIC LECTURE

Present and future of the biomarkers in Alzheimer’s disease.
Alberto Lleó, Department of Neurology, Hospital de la Santa Creu i Sant Pau, Biomedical Research Institute Sant Pau, Universitat Autònoma de Barcelona.

Chair: Carlos de Linares, Clínica de Memoria Dr. Linares, Málaga.

12:00 – 12:30 LECTURE

The role of behavioral impairment in preclinical diagnosis of dementia.
José María García-Alberca, Alzheimer Research Center and Memory Clinic, Andalusian Institute for Neuroscience (IANEC), Malaga.

12:30 – 13:45 SESSION: INNOVATIVE STRATEGIES IN TREATMENT (II)

Chair: Francisco Garzón, Hospital Clínico Virgen de la Victoria, Málaga.

Plasma exchange with albumin: Effectiveness on the amyloid concentrations and cognition in patients with Alzheimer’s disease.
Antonio Páez, Grifols, Barcelona, Mercé Boada, Fundació ACE, Barcelona, CIBERNED.

ALFA Study. First results and future perspectives.
Gonzalo Sánchez-Benavides, BarcelonaBeta Brain Research Center, Pasqual Maragall Foundation, Barcelona.

Immunotherapy against Alzheimer’s disease: abvac40, an active anti-aβ40 vaccine.
Pedro Pesini, Araclon Biotech, Zaragoza.

13:45 – 14:00 CLOSING CEREMONY

UNTIL APRIL 23TH FROM APRIL 24TH
CONFERENCE    
Professionals 290 € 340 €
(*) MIR / PIR 215 € 265 €
(**) PRE-CONFERENCE COURSE 110 € 160 €
III SYMPOSIUM ON DEMENTIA GENETICS Free registration

(*) They will have to send accreditation document.

(**) In order to attend the Pre-Conference Course it is necessary to be registered in the Conference. All course attendees will receive a free copy of the book: Alzheimer’s Disease. Non-pharmacological therapies for psychological and behavioural symptoms, written by Dr. José María García-Alberca.

Prices 21% VAT not included

Conference Venue

Institute of Port Studies
Port of Málaga
Tel. 952 12 50 11
Málaga

CALL FOR POSTERS

BASES

Those interested in submitting poster communications should send an email attaching the poster ABSTRACT to info@ianec.es, including in the subject line the text “POSTER ABSTRACT”.
The abstract must be a maximum of 300 words and must include the following data: title, surname and first name of the authors, surname and first name of the contact person. City, province, postal code, country, contact telephone, contact Email and organization..

• The deadline for abstract submission is 22/04/2019.

• The maximum measurements will be 120 cm high X 90 cm wide. A maximum of three posters may be submitted by the same author.

• At least one of the authors of the poster must be registered at the Conference in order for the acceptance of the poster to be definitive. Irrespective of the above, if other authors of the poster wish to attend the Conference sessions, they must be registered at the Conference.

• Each accepted poster will receive a free copy of the book: Alzheimer’s Disease. Non-pharmacological therapies for psychological and behavioral symptoms, written by Dr. José María García-Alberca.

Presenters

Dr. José María García-Alberca,

Alzheimer Treatment and Research Center, Andalusian Institute for Neuroscience (IANEC), Málaga.

Marcelo Berthier,

Centro de Investigaciones Médico-Sanitarias (CIMES), University of Málaga.

Tamara Marín,

Instituto AAlzheimer Treatment and Research Center, Andalusian Institute for Neuroscience (IANEC), Malaga.

Jordi Clarimón,

Hospital de la Santa Creu i Sant Pau, Barcelona; CIBERNED.

Agustín Ruiz,

Research Center and Memory Clinic, Fundació ACE, Institut Català de Neurociències Aplicades, Barcelona; CIBERNED.

Cristóbal Carnero Pardo,

Hospital Universitario Virgen de las Nieves, Fidyan Neurocenter, Granada.

Mercè Boada,

Research Center and Memory Clinic, Fundació ACE, Institut Català de Neurociències Aplicades, Barcelona.

Antonia Gutiérrez Pérez,

Institute of Biomedical Research of Málaga (IBIMA), University of Málaga.

Javier Vitorica Ferrández.

Institute of Biomedicine of Seville (IBIS), University of Seville.

Miguel Medina,

CIBERNED, Reina Sofia Foundation, CIEN Foundation.

Ángeles Martín Requero,

Centro de Investigaciones Biológicas (CSIC), CIBERER, Madrid.

Francisco Wandosell,

Severo Ochoa Molecular Biology Centre (CSIC), CIBERNED, Madrid.

Elena Vila,

Quiron Salud Hospital, Málaga.

Carlos de Linares,

Clínica de memoria Dr. Linares, Málaga.

Gonzalo Sánchez-Benavides,

BarcelonaBeta Brain Research Center, Fundació Pasqual Maragall, Barcelona.

José Luis Royo,

University of Málaga.

Antonio Páez,

Grifols, Barcelona

Fermín Mayoral,

Malaga Biomedical Research Institute (IBIMA)

José Luis Molinuevo,

Alzheimer’s Disease and Other Cognitive Disorders Unit, IDIBAPS, Hospital Clinic, Barcelona. BarcelonaBeta Brain Research Center, Fundació Pasqual Maragall, Barcelona.

Miguel Ángel Barbancho,

Centro de Investigaciones Médico-Sanitarias (CIMES), University of Málaga.

Esteban Orenes,

University of Murcia

José Luis Cantero,

Laboratory of Functional Neuroscience, Pablo de Olavide University, Seville.

Pascual Sánchez-Juan,

Marqués de Valdecilla University Hospital, Santander.

Manuel Gonçalves Pereira,

Universidade Nova de Lisboa, Portugal.

José Manuel Marín Carmona,

Municipal Memory and Dementia Programme, Malaga City Council.

José Antonio López Trigo,

President of the Spanish Society of Geriatrics and Gerontology.

Carolina López de Luis,

Centro de Referencia Estatal de Atención a Personas con Enfermedad de Alzheimer y otras Demencias, Salamanca.

Pablo Lara,

Centro de Investigaciones Médico-Sanitarias (CIMES), University of Málaga.

Manel Sánchez Pérez,

Psychiatry Service, Hospital Sagrat Cor, Martorell, Barcelona.

Angel Strainer,

Center for Alzheimer Research, Karolinska Institutet, Stockholm, Sweden.

Alberto Lleó,

Department of Neurology, Hospital de la Santa Creu i Sant Pau, Biomedical Research Institute Sant Pau, Universitat Autònoma de Barcelona; CIBERNED.

Pedro Pesini,

Araclon Biotech, Zaragoza.

Ángela García Cañete,

Andalusian Confederation Family Associations of Alzheimer’s Patients (ConFEAFA).

Esther Gris,

Alzheimer Treatment and Research Center, Andalusian Institute for Neuroscience (IANEC), Malaga.

Natalia García Casares,

Centro de Investigaciones Médico-Sanitarias (CIMES), University of Málaga.

Francisco Garzón,

Dementia Unit, Hospital Clínico Virgen de la Victoria, Málaga.

Saray Hevilla,

Alzheimer Treatment and Research Center, Andalusian Institute of Neuroscience (IANEC), Malaga.

Sponsors

With the endorsement of

Registration form

Payment:

Bank deposit in Banco Sabadell: ES52 0081 7440 1700 0190 1991

Please make payment directly into our bank account and don't forget to send us the receipt by email at info@ianec.es.

Once the inscription is made, the amount will not be returned.